Authors

The FDA Approval of Keytruda Qlex: A Subcutaneous Version of Pembrolizumab

Keytruda Qlex is a subcutaneous formulation of pembrolizumab that offers a faster, more convenient alternative to IV administration with comparable efficacy.

Q&A: Pharmacists' Role in CKD Grows as Finerenone Eyes Label Expansion

Brendon Neuen, MBBS, PhD, discusses FIND-CKD findings showing finerenone benefits nondiabetic chronic kidney disease (CKD), glomerular disease, and combination SGLT2i therapy.

The Pharmacy Model Is Changing

Embracing artificial intelligence and other tools will be necessary to push the field forward.

The Evolving Fellowship Application Process

The process provides an opportunity for personal and professional growth.

Newly Approved Specialty Drugs Advance Care for Inflammatory and Autoimmune Diseases

The Pharmacist’s Role in MS Supplement Safety

In an interview with Pharmacy Times at the Consortium of Multiple Sclerosis Centers 2026, Julie Kidd, PhD, MPH, BCPS, the director of clinical services at Blue Ridge Neurology, presenting on Supplements in Multiple Sclerosis, discussed what the pharmacist's role in MS supplement safety.

Optimizing Infusion Chair Time for Oncology Trials: Follow-Up Study

This study evaluated factors affecting the duration of the infusion appointment times for 392 clinical trial patients.

Two Weeks In: What the Medicare GLP-1 Bridge Actually Looks Like at the Counter

The first 2 weeks have produced a specific, recurring set of counter-level problems that have nothing to do with clinical appropriateness.

From Assessment to Discharge: Pharmacists Drive Safer, Patient-Centered Acute Pain Management

In an interview with Pharmacy Times, Brandon Kasberg, PharmD, discusses how pharmacists can help individualize multimodal acute pain regimens, reduce unnecessary opioid exposure, and support safer transitions from inpatient or postoperative care to the outpatient setting.

Afamitresgene autoleucel: The First T-Cell Receptor Therapy on the Market

Second-line and later treatment options for synovial sarcoma are limited. Afamitresgene autoleucel is the first FDA-approved T-cell receptor therapy, demonstrating long-lasting responses and tolerable adverse effects in pretreated patients.

Updated European MASLD Guidelines Review Prevention, Screening, and Treatments

Patients should be supported by a multidisciplinary team, frequent evaluations, and behavioral therapy for optimal care.

Deficiency in Care: Underutilization of Intravenous Iron for Acute Heart Failure

Ferric carboxymaltose is effective and guideline-endorsed, yet underutilized due to high cost and system-level barriers.

Is VER-01 a Turning Point for Cannabis-Derived Medicines?

In an interview with Pharmacy Times, Erin J. Walsh, PharmD, MS, RPh, discusses where VER-01 could fit within chronic pain management and why advances in standardized cannabinoid therapies may represent a pivotal moment for the future of evidence-based cannabis-derived medicines.

Levorphanol Safety and Clinical Practice: Risk Reduction, Workflow Impact, and the Pharmacist’s Role in Opioid Rotation

Pharmacy Times interviews Benjamin Kematick, PhD, BCACP, BCPMP, and explores the safety profile of Levorphanol compared with methadone, including potential reductions in risks such as accumulation, QT prolongation, and drug interactions, as well as its implications for clinical workflows and the pharmacist’s role in supporting safe opioid rotation, monitoring, and patient counseling.

Meet the FDA’s Newly Approved OTC Sunscreen Ingredient: Bemotrizinol

In modernizing sunscreen options, the FDA has added the first new organic active ingredient, bemotrizinol, to the OTC sunscreen monograph.

What the Removal of Black Box Warnings Means for Women, Hormone Therapies, and Pharmacists

Pharmacists guide women through updated menopause hormone therapy labels, rising demand, patch shortages, and personalized risk-benefit counseling.

Wildfires and Respiratory Health: A Pharmacist's FAQ on Protecting Patients With Asthma, COPD, and Allergies

As 2026 wildfire smoke from Canada blankets the US, pharmacists can facilitate early refills, counsel on protective measures, and help patients understand when worsening symptoms require emergency care.

Standardizing Supplement Recommendations in a Neuro-Oncology Clinic: A Pharmacist-Led Quality Improvement Initiative

This abstract was presented at the Oncology Pharmacists Connect (OPC) meeting in Austin, Texas, from June 18 to 19, 2026.

How the PATINA Regimen Advances Maintenance Therapy for HR-Positive, HER2-Positive Metastatic Breast Cancer

Adding palbociclib to anti-HER2 and endocrine maintenance therapy provides a new treatment option for patients with HR-positive, HER2-positive metastatic breast cancer.

DPYD Testing Gains Ground: NCCN Guideline Update Reflects Decades of Work Toward Safer Chemotherapy

Navigating Pediatric Atopic Dermatitis: Insights Into Treatment, Challenges, and Care Considerations

Atopic dermatitis significantly impacts quality of life, and requires personalized management through trigger identification, skin barrier maintenance, and a range of topical, oral, and biologic therapies to reduce symptoms and prevent flare-ups.

FGFR Inhibitors for Treatment of Primary CNS Tumors

This abstract was presented at the Oncology Pharmacists Connect (OPC) meeting in Austin, Texas, from June 18 to 19, 2026.

HOPA 2025: Insights Into Post-Transplant Cyclophosphamide Use for Graft-Versus-Host Disease Prevention

Lauren Dietz, PharmD, highlighted the role of oncology pharmacists in guiding prophylaxis decisions to optimize transplant outcomes.

Essential Oils: A Pharmacist Guide for Alternative Pain Management

With Growing Patient Interest in Natural Remedies, Pharmacists Must Understand the Science, Safety, and Limitations of Essential Oils

What Hemophilia and Sickle Cell Disease Reveal About the Future of Gene Therapy Access

Alex Wolff, PharmD, BCOP, FHOPA, explains how patient populations, delivery models, and safety risks shape real-world implementation.

Improving Inpatient REMS Documentation Compliance With a Wildcard Checkpoint

Using wildcard hard-stop pharmacy preparation instructions in the electronic health record system significantly improved REMs documentation compliance at our institution.

Neuriva: A Closer Look at the Efficacy and Safety of this Popular Supplement

Administration of Tivozanib via Gastrostomy Tube: A Pharmacokinetic Analysis

This abstract was presented at the Oncology Pharmacists Connect (OPC) meeting in Austin, Texas, from June 18 to 19, 2026.

Hypertension: A Silent Killer Requiring Novel Therapies

Hypertension is widespread and linked to serious health risks, but new treatments for resistant cases target new mechanisms of action.

Half of Pharmacy Technicians Feel Fulfilled in Their Current Role

The Connecticut Society of Health-System Pharmacists Technician Committee survey explores the perception of career growth opportunities and challenges.